+49 761-389 49-0
to support the development, validation, and routine determination of HRD status in cancer patients.
Highly multiplexed, biosynthetic DNA, RNA and ctDNA reference materials for NGS-based assays designed to analyze hematologic malignancies such as Myeloid Leukemia and Lymphoma.
To help clinical labs performing NGS-based BRCA testing
We are a proud distributor of NGeneBio
LGC Seracare's positives Referenzmaterialien enthält das gesamte SARS-CoV-2-Genom und negatives Material, das auf das menschliche RNase P-Gen abzielt. Es ist so konzipiert, dass es die tägliche Leistungsfähigkeit des Assays misst und sowohl eine positive als auch eine negative Referenzlösung liefert.
AccuPlex™ SARS-CoV-2 Omicron Variant Reference Material Kit contains the full SARS-CoV-2 genomic RNA with a focus on S and N-gene mutations within the Omicron variant of concern (VOC) B.1.1.529. The kit contains one positive vial for the Omicron variant as well as a SARS-CoV-2 wild type (reference sequence NC_045512) control vial. An RNase P negative control vial is also included.
The RT-PCR assay is designed for the unequivocal detection of the Omicron (B.1.1.529) and Delta (B.1.617.2) variants (Variants of Concern (VOC)) of SARS-CoV-2 from biological samples.
The AccuPlex SARS-CoV-2 Molecular Controls Kit – Full Genome contains positive reference materials for the entire SARS-CoV-2 genome. Also includes negative materials targeting the human RNase P gene. It is designed to measure day-to-day performance of the assay, providing both a positive and a negative reference solution.